Search Results for "Sk Biopharmaceuticals Korea"

03:36 EST 7th February 2016 | BioPortfolio

Matching Channels


BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...

BioPortfolio Twitter Accounts

BioPortfolio has created approx 200 Twitter accounts with currently (June 2015 - 46,000 Twitter Followers) to support our users interest in keeping upto date on the latest news, research papers, rep...

Matching News

CPhI Korea opens as South Korea emerges as global leader in biosimilar trials

CPhI Korea, organised by UBM EMEA, will return to the COEX in Seoul, South Korea โ€“ 7 to 9 September 2015 โ€“ following a successful inaugural event last year... The post CPhI Korea opens as South Ko...

KDDF, J&J Launch Joint Korea Diabetes R&D Program

South Korea is continuing to step up open innovation initiatives with the multinational pharma sector, with the aim of accelerating global licensing out deals by domestic companies. In its latest effo...

CPhI Korea returns three times bigger

Following its successful launch last year, CPhI Korea returns with three times the exhibition space to the COEX in Seoul, South Korea, on 7โ€“9 September 2015.

Korea Mulls New Biosimilar Guidelines As Pipeline Surges

As more biosimilar products are set to be released in South Korea, with a hefty number of ongoing late-stage clinical trials, the country is seeking to introduce a new separate guideline for insulin b...

The dynamic evolution of rheumatology in Korea

During the past 35 years rheumatology in Korea has progressed remarkably swiftly in terms of academic activity, clinical practice and health care. However, the future of rheumatology in Korea requires...

ASLAN and Hyundai Partner on Cancer Drug in Korea

ASLAN Pharma, a Singapore-based cancer company, will collaborate with Hyundai Pharm Co. to develop and commercialize ASLAN001 for cholangiocarcinoma (CCA) in South Korea. ASLAN001 is a small molecule ...

BRIEF-Bionaturis in consortium to develop biopharmaceuticals 

* Says it will take part in consortium BIOMAP to design tests and to develop biopharmaceuticals

Allergan wraps up $2.1B purchase of Kythera Biopharmaceuticals

Allergan's purchase of Kythera Biopharmaceuticals has been completed for about $2.1 billion.  -More- 

Matching PubMed Articles

A nationwide study of patients hospitalised for poisoning in Korea based on Korea National Hospital Discharge In-Depth Injury Survey data from 2005 to 2009.

In light of the need to develop an integrated database on poisoning incidents in Korea, this study seeks to determine the characteristics of poisoning incidents in Korea by age, gender, location of in...

Copycat Suicide Induced by Entertainment Celebrity Suicides in South Korea.

Throughout the past several years, there have been a number of entertainment celebrity suicides in South Korea. The aim of this study was to investigate the clustering of suicides following celebritie...

Impact of the new payment system on laparoscopic appendectomy in Korea.

Korea has a nationalized health system. The aim of this study was to evaluate the impact of the Korea diagnosis related group-based prospective payment system (K-DRG/PPS) on the use of medical resourc...

National trends for the treatment of peripheral arterial disease in Korea between 2004 and 2013.

Peripheral arterial disease (PAD) has been a major public health issue in the elderly. Advances in endovascular surgery have led to a substantial shift in the management of PAD. Although the nationwid...

Prevalence of Optic Disc Hemorrhage in Korea: The Korea National Health and Nutrition Examination Survey.

We determined the prevalence of disc hemorrhage (DH) and the associated factors of DH in a large Korean population based on the data from the nationwide cross-sectional survey, the Korea National Heal...

Search Whole site using Google

Quick Search
Advertisement Advertisement